El Kendi Pharmaceutical

ORTHOCAM

ORTHOCAM®

References: PIROXICAM

FORM : Dispersible scored tablet.

DOSAGE : 20mg.

PRESENTATION : Box of 10 tablets.

DIRECTIONS :

• Piroxicam is indicated for the symptomatic treatment of osteoarthritis, rheumatoid arthritis or ankylosing spondylitis. Due to its safety profile, Piroxicam should not be used as first-line treatment when treatment with NSAIDs is indicated.
• The decision to prescribe a specialty containing Piroxicam must be based on the assessment of all the risks specific to each patient.

DOSAGE :

Specialty prescription containing Piroxicam should be initiated by physicians experienced in the diagnosis and treatment of patients with inflammatory or degenerative rheumatic diseases.

The maximum recommended daily dose is 20 mg.

The occurrence of adverse effects can be minimized by using the lowest possible dose needed to relieve symptoms for the shortest duration of treatment. The benefit and the safety of the treatment must be reassessed within 14 days. If continued treatment is necessary, it should be accompanied by frequent reassessments.

Since Piroxicam has been associated with an increased risk of gastrointestinal complications, the possibility of using gastric mucosal protective therapy (eg, misoprostol or proton pump inhibitors) should be seriously considered. , especially for the elderly.

FORM : GEL.

DOSAGE : 0.5%.

PRESENTATION : Tube of 25 g.

DIRECTIONS :

• Local treatment of trauma caused by post-traumatic osteoarthritis.
• Acute skeletal muscle disorders.
• Rheumatic diseases.

DOSAGE : 2 to 4 applications per day.